News >

Updated Data Unveiled With Emerging Treatments in Myeloma

Ellie Leick
Published: Thursday, Jan 23, 2020

Sandy W. Wong, MD, an assistant clinical professor in the Division of Hematology/Oncology, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center

Sandy W. Wong, MD
Updated data on several emerging treatment modalities in multiple myeloma were presented at the 2019 ASH Annual Meeting, including CAR T-cell therapy, antibody-drug conjugates (ADCs), bispecific T-cell engagers (BiTEs), and a novel selinexor (Xpovio) combination, explained Sandy W. Wong, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication